nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—type 2 diabetes mellitus—metabolic syndrome X	0.577	1	CtDrD
Rosiglitazone—PPARG—metabolic syndrome X	0.224	0.727	CbGaD
Rosiglitazone—ALB—metabolic syndrome X	0.0843	0.273	CbGaD
Rosiglitazone—Ketonuria—Metformin—metabolic syndrome X	0.012	0.482	CcSEcCtD
Rosiglitazone—PPARG—brown adipose tissue—metabolic syndrome X	0.00345	0.179	CbGeAlD
Rosiglitazone—PPARG—artery—metabolic syndrome X	0.00152	0.079	CbGeAlD
Rosiglitazone—Pioglitazone—PPARG—metabolic syndrome X	0.00151	1	CrCbGaD
Rosiglitazone—PPARG—endothelium—metabolic syndrome X	0.00128	0.0667	CbGeAlD
Rosiglitazone—PPARG—blood vessel—metabolic syndrome X	0.00118	0.0615	CbGeAlD
Rosiglitazone—ACSL4—cardiovascular system—metabolic syndrome X	0.00117	0.061	CbGeAlD
Rosiglitazone—ACSL4—adipose tissue—metabolic syndrome X	0.00103	0.0538	CbGeAlD
Rosiglitazone—Hypoglycaemia—Metformin—metabolic syndrome X	0.000841	0.0338	CcSEcCtD
Rosiglitazone—PTGS1—artery—metabolic syndrome X	0.000812	0.0422	CbGeAlD
Rosiglitazone—Nasopharyngitis—Metformin—metabolic syndrome X	0.000734	0.0295	CcSEcCtD
Rosiglitazone—ACSL4—liver—metabolic syndrome X	0.000725	0.0377	CbGeAlD
Rosiglitazone—PTGS1—endothelium—metabolic syndrome X	0.000686	0.0357	CbGeAlD
Rosiglitazone—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000659	0.0265	CcSEcCtD
Rosiglitazone—PTGS1—blood vessel—metabolic syndrome X	0.000632	0.0329	CbGeAlD
Rosiglitazone—SLCO1B1—kidney—metabolic syndrome X	0.000599	0.0311	CbGeAlD
Rosiglitazone—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000598	0.0241	CcSEcCtD
Rosiglitazone—Hepatitis—Metformin—metabolic syndrome X	0.000568	0.0228	CcSEcCtD
Rosiglitazone—Oedema peripheral—Metformin—metabolic syndrome X	0.000559	0.0225	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Metformin—metabolic syndrome X	0.000558	0.0224	CcSEcCtD
Rosiglitazone—CYP2A6—adipose tissue—metabolic syndrome X	0.000546	0.0284	CbGeAlD
Rosiglitazone—Eye disorder—Metformin—metabolic syndrome X	0.00053	0.0213	CcSEcCtD
Rosiglitazone—PPARG—cardiovascular system—metabolic syndrome X	0.000528	0.0274	CbGeAlD
Rosiglitazone—Cardiac disorder—Metformin—metabolic syndrome X	0.000527	0.0212	CcSEcCtD
Rosiglitazone—PPARG—kidney—metabolic syndrome X	0.000516	0.0269	CbGeAlD
Rosiglitazone—Immune system disorder—Metformin—metabolic syndrome X	0.000513	0.0206	CcSEcCtD
Rosiglitazone—Malnutrition—Metformin—metabolic syndrome X	0.000494	0.0199	CcSEcCtD
Rosiglitazone—PPARG—adipose tissue—metabolic syndrome X	0.000465	0.0242	CbGeAlD
Rosiglitazone—Hypertension—Metformin—metabolic syndrome X	0.000427	0.0172	CcSEcCtD
Rosiglitazone—Myalgia—Metformin—metabolic syndrome X	0.000421	0.0169	CcSEcCtD
Rosiglitazone—Oedema—Metformin—metabolic syndrome X	0.000403	0.0162	CcSEcCtD
Rosiglitazone—Infection—Metformin—metabolic syndrome X	0.000401	0.0161	CcSEcCtD
Rosiglitazone—Nervous system disorder—Metformin—metabolic syndrome X	0.000395	0.0159	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Metformin—metabolic syndrome X	0.000395	0.0159	CcSEcCtD
Rosiglitazone—CYP2A6—liver—metabolic syndrome X	0.000383	0.0199	CbGeAlD
Rosiglitazone—SLCO1B1—liver—metabolic syndrome X	0.000378	0.0197	CbGeAlD
Rosiglitazone—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000367	0.0148	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000348	0.014	CcSEcCtD
Rosiglitazone—Fatigue—Metformin—metabolic syndrome X	0.000348	0.014	CcSEcCtD
Rosiglitazone—Constipation—Metformin—metabolic syndrome X	0.000345	0.0139	CcSEcCtD
Rosiglitazone—CYP2C8—kidney—metabolic syndrome X	0.00034	0.0177	CbGeAlD
Rosiglitazone—PPARG—liver—metabolic syndrome X	0.000326	0.017	CbGeAlD
Rosiglitazone—Urticaria—Metformin—metabolic syndrome X	0.00032	0.0129	CcSEcCtD
Rosiglitazone—CYP2C9—cardiovascular system—metabolic syndrome X	0.000309	0.0161	CbGeAlD
Rosiglitazone—ALB—liver—metabolic syndrome X	0.000306	0.0159	CbGeAlD
Rosiglitazone—Asthenia—Metformin—metabolic syndrome X	0.000289	0.0116	CcSEcCtD
Rosiglitazone—Pruritus—Metformin—metabolic syndrome X	0.000285	0.0115	CcSEcCtD
Rosiglitazone—PTGS1—cardiovascular system—metabolic syndrome X	0.000282	0.0147	CbGeAlD
Rosiglitazone—PTGS1—kidney—metabolic syndrome X	0.000276	0.0144	CbGeAlD
Rosiglitazone—Diarrhoea—Metformin—metabolic syndrome X	0.000276	0.0111	CcSEcCtD
Rosiglitazone—Dizziness—Metformin—metabolic syndrome X	0.000267	0.0107	CcSEcCtD
Rosiglitazone—Rash—Metformin—metabolic syndrome X	0.000254	0.0102	CcSEcCtD
Rosiglitazone—Dermatitis—Metformin—metabolic syndrome X	0.000254	0.0102	CcSEcCtD
Rosiglitazone—Headache—Metformin—metabolic syndrome X	0.000253	0.0102	CcSEcCtD
Rosiglitazone—PTGS1—adipose tissue—metabolic syndrome X	0.000249	0.0129	CbGeAlD
Rosiglitazone—CYP2C19—liver—metabolic syndrome X	0.000246	0.0128	CbGeAlD
Rosiglitazone—Nausea—Metformin—metabolic syndrome X	0.00024	0.00964	CcSEcCtD
Rosiglitazone—CYP2D6—kidney—metabolic syndrome X	0.000227	0.0118	CbGeAlD
Rosiglitazone—CYP2C8—liver—metabolic syndrome X	0.000215	0.0112	CbGeAlD
Rosiglitazone—CYP1A2—liver—metabolic syndrome X	0.000201	0.0105	CbGeAlD
Rosiglitazone—CYP2C9—liver—metabolic syndrome X	0.000191	0.00994	CbGeAlD
Rosiglitazone—CYP2D6—liver—metabolic syndrome X	0.000143	0.00746	CbGeAlD
Rosiglitazone—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	6.99e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	6.99e-06	0.000101	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NAMPT—metabolic syndrome X	6.98e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.98e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LIPC—metabolic syndrome X	6.98e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GCK—metabolic syndrome X	6.98e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	6.97e-06	0.000101	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.94e-06	0.0001	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GCK—metabolic syndrome X	6.94e-06	0.0001	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LIPC—metabolic syndrome X	6.94e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOC3—metabolic syndrome X	6.94e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	6.93e-06	0.0001	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA5—metabolic syndrome X	6.92e-06	9.98e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOB—metabolic syndrome X	6.91e-06	9.97e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOC3—metabolic syndrome X	6.9e-06	9.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	6.88e-06	9.93e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SERPINE1—metabolic syndrome X	6.87e-06	9.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA5—metabolic syndrome X	6.86e-06	9.9e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—AKT1—metabolic syndrome X	6.83e-06	9.86e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	6.78e-06	9.78e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—INS—metabolic syndrome X	6.74e-06	9.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CETP—metabolic syndrome X	6.73e-06	9.72e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	6.72e-06	9.7e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CETP—metabolic syndrome X	6.7e-06	9.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	6.66e-06	9.61e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	6.65e-06	9.6e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—LPL—metabolic syndrome X	6.59e-06	9.52e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS3—metabolic syndrome X	6.56e-06	9.47e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARA—metabolic syndrome X	6.55e-06	9.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOB—metabolic syndrome X	6.53e-06	9.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	6.52e-06	9.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	6.45e-06	9.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	6.45e-06	9.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	6.43e-06	9.28e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SCARB1—metabolic syndrome X	6.41e-06	9.26e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—G6PD—metabolic syndrome X	6.41e-06	9.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	6.37e-06	9.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PLA2G4A—metabolic syndrome X	6.35e-06	9.17e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AGT—metabolic syndrome X	6.34e-06	9.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	6.32e-06	9.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.28e-06	9.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	6.27e-06	9.05e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CD36—metabolic syndrome X	6.27e-06	9.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	6.26e-06	9.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	6.25e-06	9.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—LPL—metabolic syndrome X	6.24e-06	9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	6.23e-06	9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LIPC—metabolic syndrome X	6.23e-06	8.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GCK—metabolic syndrome X	6.23e-06	8.99e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SREBF1—metabolic syndrome X	6.23e-06	8.99e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOE—metabolic syndrome X	6.21e-06	8.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOC3—metabolic syndrome X	6.19e-06	8.94e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—metabolic syndrome X	6.18e-06	8.92e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOA1—metabolic syndrome X	6.14e-06	8.87e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPA—metabolic syndrome X	6.11e-06	8.82e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCKR—metabolic syndrome X	6.11e-06	8.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	6.09e-06	8.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GOT2—metabolic syndrome X	6.09e-06	8.79e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMGCR—metabolic syndrome X	6.06e-06	8.74e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GOT2—metabolic syndrome X	6.06e-06	8.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CETP—metabolic syndrome X	6.01e-06	8.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CD36—metabolic syndrome X	5.93e-06	8.55e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	5.92e-06	8.54e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NOS3—metabolic syndrome X	5.91e-06	8.53e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	5.88e-06	8.48e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA5—metabolic syndrome X	5.86e-06	8.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	5.85e-06	8.44e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARA—metabolic syndrome X	5.83e-06	8.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	5.77e-06	8.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	5.76e-06	8.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GCK—metabolic syndrome X	5.73e-06	8.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LIPC—metabolic syndrome X	5.73e-06	8.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	5.72e-06	8.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOC3—metabolic syndrome X	5.7e-06	8.22e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	5.69e-06	8.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	5.68e-06	8.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LIPC—metabolic syndrome X	5.68e-06	8.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GCK—metabolic syndrome X	5.68e-06	8.2e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOC3—metabolic syndrome X	5.65e-06	8.15e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AGT—metabolic syndrome X	5.64e-06	8.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.6e-06	8.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	5.59e-06	8.07e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	5.58e-06	8.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CETP—metabolic syndrome X	5.53e-06	7.98e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOE—metabolic syndrome X	5.53e-06	7.98e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	5.51e-06	7.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARA—metabolic syndrome X	5.51e-06	7.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.49e-06	7.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CETP—metabolic syndrome X	5.48e-06	7.91e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOA1—metabolic syndrome X	5.46e-06	7.89e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.46e-06	7.88e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	5.45e-06	7.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	5.44e-06	7.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GOT2—metabolic syndrome X	5.44e-06	7.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	5.43e-06	7.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	5.43e-06	7.84e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—metabolic syndrome X	5.41e-06	7.81e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—metabolic syndrome X	5.41e-06	7.8e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCA1—metabolic syndrome X	5.4e-06	7.79e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SLC2A4—metabolic syndrome X	5.4e-06	7.79e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AGT—metabolic syndrome X	5.33e-06	7.7e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—INS—metabolic syndrome X	5.31e-06	7.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	5.29e-06	7.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GGT1—metabolic syndrome X	5.26e-06	7.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GOT1—metabolic syndrome X	5.26e-06	7.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	5.25e-06	7.58e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GGT1—metabolic syndrome X	5.23e-06	7.55e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GOT1—metabolic syndrome X	5.23e-06	7.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOE—metabolic syndrome X	5.23e-06	7.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOA1—metabolic syndrome X	5.17e-06	7.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	5.14e-06	7.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	5.11e-06	7.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	5.1e-06	7.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GOT2—metabolic syndrome X	5e-06	7.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	5e-06	7.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	4.96e-06	7.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GOT2—metabolic syndrome X	4.96e-06	7.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.9e-06	7.08e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	4.89e-06	7.05e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—metabolic syndrome X	4.87e-06	7.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	4.86e-06	7.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LIPC—metabolic syndrome X	4.85e-06	7.01e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GCK—metabolic syndrome X	4.85e-06	7.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	4.85e-06	6.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	4.85e-06	6.99e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOC3—metabolic syndrome X	4.82e-06	6.96e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—metabolic syndrome X	4.81e-06	6.95e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—INS—metabolic syndrome X	4.72e-06	6.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GOT1—metabolic syndrome X	4.69e-06	6.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GGT1—metabolic syndrome X	4.69e-06	6.77e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CETP—metabolic syndrome X	4.68e-06	6.76e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—metabolic syndrome X	4.66e-06	6.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—metabolic syndrome X	4.55e-06	6.57e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	4.49e-06	6.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	4.47e-06	6.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—INS—metabolic syndrome X	4.47e-06	6.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOB—metabolic syndrome X	4.46e-06	6.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	4.46e-06	6.43e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	4.46e-06	6.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOB—metabolic syndrome X	4.44e-06	6.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	4.42e-06	6.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	4.42e-06	6.38e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	4.37e-06	6.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	4.35e-06	6.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	4.34e-06	6.26e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—metabolic syndrome X	4.34e-06	6.26e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—metabolic syndrome X	4.33e-06	6.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GGT1—metabolic syndrome X	4.32e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GOT1—metabolic syndrome X	4.32e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PLA2G4A—metabolic syndrome X	4.31e-06	6.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GGT1—metabolic syndrome X	4.28e-06	6.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GOT1—metabolic syndrome X	4.28e-06	6.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LPL—metabolic syndrome X	4.26e-06	6.15e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—metabolic syndrome X	4.26e-06	6.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	4.24e-06	6.11e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT2—metabolic syndrome X	4.24e-06	6.11e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LPL—metabolic syndrome X	4.24e-06	6.11e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—metabolic syndrome X	4.14e-06	5.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—metabolic syndrome X	4.09e-06	5.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD36—metabolic syndrome X	4.05e-06	5.84e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD36—metabolic syndrome X	4.02e-06	5.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOB—metabolic syndrome X	3.98e-06	5.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—metabolic syndrome X	3.92e-06	5.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	3.87e-06	5.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	3.82e-06	5.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LPL—metabolic syndrome X	3.8e-06	5.49e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—metabolic syndrome X	3.79e-06	5.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	3.78e-06	5.45e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	3.78e-06	5.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARA—metabolic syndrome X	3.76e-06	5.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARA—metabolic syndrome X	3.74e-06	5.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOB—metabolic syndrome X	3.66e-06	5.29e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GGT1—metabolic syndrome X	3.66e-06	5.28e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GOT1—metabolic syndrome X	3.66e-06	5.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—metabolic syndrome X	3.64e-06	5.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOB—metabolic syndrome X	3.63e-06	5.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—metabolic syndrome X	3.62e-06	5.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD36—metabolic syndrome X	3.61e-06	5.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—metabolic syndrome X	3.58e-06	5.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOE—metabolic syndrome X	3.57e-06	5.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	3.56e-06	5.14e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOE—metabolic syndrome X	3.55e-06	5.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	3.53e-06	5.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOA1—metabolic syndrome X	3.53e-06	5.1e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOA1—metabolic syndrome X	3.51e-06	5.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LPL—metabolic syndrome X	3.5e-06	5.05e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—metabolic syndrome X	3.49e-06	5.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LPL—metabolic syndrome X	3.47e-06	5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARA—metabolic syndrome X	3.36e-06	4.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD36—metabolic syndrome X	3.32e-06	4.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD36—metabolic syndrome X	3.29e-06	4.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—metabolic syndrome X	3.25e-06	4.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOE—metabolic syndrome X	3.19e-06	4.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOA1—metabolic syndrome X	3.15e-06	4.55e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—metabolic syndrome X	3.11e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOB—metabolic syndrome X	3.1e-06	4.48e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—metabolic syndrome X	3.09e-06	4.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARA—metabolic syndrome X	3.09e-06	4.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARA—metabolic syndrome X	3.06e-06	4.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—INS—metabolic syndrome X	3.05e-06	4.4e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—INS—metabolic syndrome X	3.03e-06	4.38e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	3.02e-06	4.36e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—metabolic syndrome X	3.02e-06	4.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—metabolic syndrome X	2.99e-06	4.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—metabolic syndrome X	2.97e-06	4.28e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPL—metabolic syndrome X	2.96e-06	4.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOE—metabolic syndrome X	2.93e-06	4.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOE—metabolic syndrome X	2.91e-06	4.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA1—metabolic syndrome X	2.9e-06	4.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA1—metabolic syndrome X	2.87e-06	4.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD36—metabolic syndrome X	2.81e-06	4.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—metabolic syndrome X	2.8e-06	4.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—metabolic syndrome X	2.78e-06	4.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—INS—metabolic syndrome X	2.72e-06	3.93e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—metabolic syndrome X	2.72e-06	3.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—metabolic syndrome X	2.67e-06	3.86e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—metabolic syndrome X	2.66e-06	3.84e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARA—metabolic syndrome X	2.62e-06	3.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—metabolic syndrome X	2.55e-06	3.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—metabolic syndrome X	2.53e-06	3.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—metabolic syndrome X	2.53e-06	3.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—INS—metabolic syndrome X	2.5e-06	3.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—metabolic syndrome X	2.5e-06	3.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOE—metabolic syndrome X	2.48e-06	3.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—INS—metabolic syndrome X	2.48e-06	3.58e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA1—metabolic syndrome X	2.45e-06	3.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	2.45e-06	3.53e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—metabolic syndrome X	2.43e-06	3.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—metabolic syndrome X	2.39e-06	3.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—metabolic syndrome X	2.3e-06	3.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—metabolic syndrome X	2.28e-06	3.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—metabolic syndrome X	2.2e-06	3.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	2.18e-06	3.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—metabolic syndrome X	2.18e-06	3.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—metabolic syndrome X	2.16e-06	3.12e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—metabolic syndrome X	2.14e-06	3.09e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—INS—metabolic syndrome X	2.12e-06	3.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	2.01e-06	2.9e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	1.99e-06	2.87e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—metabolic syndrome X	1.94e-06	2.81e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—metabolic syndrome X	1.9e-06	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—metabolic syndrome X	1.86e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—metabolic syndrome X	1.8e-06	2.6e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	1.7e-06	2.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—metabolic syndrome X	1.23e-06	1.77e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—metabolic syndrome X	1.22e-06	1.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—metabolic syndrome X	1.1e-06	1.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—metabolic syndrome X	1.01e-06	1.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—metabolic syndrome X	1e-06	1.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—metabolic syndrome X	8.55e-07	1.23e-05	CbGpPWpGaD
